Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 USD | +2.58% | -2.53% | -35.56% |
May. 15 | JPMorgan Downgrades Rallybio to Neutral From Overweight | MT |
May. 09 | Rallybio Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.56% | 64.25M | |
+45.37% | 56.65B | |
-7.33% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.30% | 26.75B | |
-21.47% | 19.03B | |
+0.69% | 12.28B | |
+24.02% | 12.26B | |
+27.17% | 12.04B |
- Stock Market
- Equities
- RLYB Stock
- News Rallybio Corporation
- JPMorgan Starts Rallybio at Overweight With $21 Price Target